查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1468169

2024-2032 年按類型、技術、適應症、最終用戶和地區分類的心臟起搏器市場

Cardiac Pacemaker Market by Type, Technology, Indication, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年全球心臟節律器市場規模達50億美元。心血管疾病盛行率不斷上升、擁有健康保險的人數不斷增加，以及為改善手術技術而進行的廣泛研發 (R&D) 活動是推動市場發展的一些關鍵因素。

心臟節律器是一種植入胸部或腹部的小型醫療設備，利用電脈衝治療心律不整，有助於調節和監測心跳。它具有電子和機械組件，例如微處理器、感測器、電極、電線、引線和外殼，並且可以根據患者的要求進行客製化。它有助於降低因心率不規則或緩慢引起的中風和心臟衰竭等併發症的風險。除此之外，心臟節律器也被整合到植入式除顫器和心臟再同步治療裝置中，以提供更全面的治療方法。目前，主要參與者正在推出小型且侵入性較小的心臟起搏器，以使患者更容易耐受，也更容易讓外科醫生植入。

心臟起搏器市場趨勢：

心血管疾病（CVD）在大眾中的盛行率激增是推動全球心臟節律器需求的主要因素之一。此外，人口老化加劇，更容易罹患心律不整、先天性心臟病和心房顫動等疾病，有利於市場成長。此外，健康意識的增強以及對心臟相關疾病可用治療替代方案的認知正在對市場產生積極影響。除此之外，越來越多的人擁有為心臟起搏器提供經濟援助並減少醫療費用的健康保險，這也促進了市場的成長。此外，領先廠商正在推出具有更長電池壽命和遠端監控功能的心臟起搏器，使醫療保健專業人員能夠使用智慧型手機遠端追蹤設備的性能和患者的心臟功能。主要參與者也致力於在心臟節律器的製造中使用生物相容性材料，以盡量減少感染和與起搏器植入相關的其他併發症的風險。除此之外，將無線技術整合到心臟起搏器中以在設備之間傳輸資料，有助於提高設備的準確性和可靠性，正在推動市場的成長。此外，許多國家的管理機構正在投資研發 (R&D) 活動，以改善手術技術並提供便利的醫療設施。

本報告回答的關鍵問題

  • 全球心臟起搏器市場有多大？
  • 2024-2032年全球心臟節律器市場的預期成長率是多少？
  • 推動全球心臟節律器市場的關鍵因素是什麼？
  • COVID-19 對全球心臟節律器市場有何影響？
  • 全球心臟節律器市場按類型分類是怎樣的？
  • 基於該技術的全球心臟節律器市場的詳細情形如何？
  • 根據適應症，全球心臟節律器市場的詳細情形如何？
  • 基於最終用戶的全球心臟節律器市場的詳細情形如何？
  • 全球心臟節律器市場的重點區域有哪些？
  • 全球心臟節律器市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球心臟節律器市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按類型

  • 植入式
    • 市場走向
    • 市場預測
  • 外部的
    • 市場走向
    • 市場預測

第 7 章：市場區隔：依技術

  • 雙心室
    • 市場走向
    • 市場預測
  • 單室
    • 市場走向
    • 市場預測
  • 雙室
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依跡象

  • 心律不整
    • 市場走向
    • 市場預測
  • 充血性心臟衰竭
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按最終用戶

  • 醫院和診所
    • 市場走向
    • 市場預測
  • 門診手術中心
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 10 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 11 章：促進因素、限制與機會

  • 概述
  • 促進要素
  • 限制
  • 機會

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Biotronik
    • Boston Scientific Corporation
    • Lepu Medical Technology (Beijing)Co. Ltd.
    • MEDICO srl
    • Medtronic plc
    • MicroPort Scientific Corporatio
    • Oscor Inc. (Integer Holdings Corporation)
    • Osypka Medical GmbH
    • Shree Pacetronix Ltd.
Product Code: SR112024A6873

The global cardiac pacemaker market size reached US$ 5.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.8 Billion by 2032, exhibiting a growth rate (CAGR) of 3.5% during 2024-2032. The increasing prevalence of CVDs, rising number of people with health insurance policies, and extensive research and development (R&D) activities for improving surgical techniques represent some of the key factors driving the market.

A cardiac pacemaker is a small medical device implanted in the chest or abdomen to treat heart rhythm disorders using electrical pulses, which assist in regulating and monitoring the heartbeat. It has electronic and mechanical components, such as microprocessors, sensors, electrodes, wires, leads, and housing, and can be customized according to the requirements of the patient. It helps reduce the risk of complications like stroke and heart failure that can be caused by an irregular or slow heart rate. Besides this, a cardiac pacemaker is incorporated into implantable defibrillators and cardiac resynchronization therapy devices to offer a more comprehensive treatment approach. At present, key players are introducing small and less invasive cardiac pacemakers to make it easier for patients to tolerate and surgeons to implant.

Cardiac Pacemaker Market Trends:

The surging prevalence of cardiovascular diseases (CVDs) among the masses represents one of the major factors driving the demand for cardiac pacemakers around the world. Moreover, the rising aging population, which is more prone to ailments, such as arrhythmias, congenital heart disease, and atrial fibrillation, is favoring the market growth. In addition, the growing health consciousness and awareness about the available treatment alternatives for heart-related ailments are influencing the market positively. Apart from this, the increasing number of people with health insurance policies that provide financial assistance for cardiac pacemakers and reduce medical expenses is contributing to the market growth. Furthermore, leading players are launching cardiac pacemakers with longer battery life and remote monitoring capabilities that allow healthcare professionals to track the performance of the device and heart function of patients remotely using a smartphone. Key players are also focusing on using biocompatible materials in the manufacturing of cardiac pacemakers to minimize the risk of infection and other complications associated with pacemaker implantation. Besides this, the integration of wireless technology in cardiac pacemakers to transmit data to and from the device that can help improve the accuracy and reliability of the device is propelling the growth of the market. Additionally, governing agencies of numerous countries are investing in research and development (R&D) activities to improve surgical techniques and provide easy access to healthcare facilities.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global cardiac pacemaker market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on type, technology, indication, and end user.

Type Insights:

Implantable

External

The report has provided a detailed breakup and analysis of the cardiac pacemaker market based on the type. This includes implantable and external. According to the report, implantable represented the largest segment.

Technology Insights:

Biventricular

Single Chambered

Dual Chambered

Others

A detailed breakup and analysis of the cardiac pacemaker market based on the technology has also been provided in the report. This includes biventricular, single chambered, dual chambered, and others. According to the report, dual chambered accounted for the largest market share.

Indication Insights:

Arrhythmias

Congestive Heart Failure

Others

The report has provided a detailed breakup and analysis of the cardiac pacemaker market based on the indication. This includes arrhythmias, congestive heart failure, and others. According to the report, arrhythmias represented the largest segment.

End User Insights:

Hospitals and Clinics

Ambulatory Surgery Centers

Others

A detailed breakup and analysis of the cardiac pacemaker market based on the end user has also been provided in the report. This includes hospitals and clinics, ambulatory surgery centers, and others. According to the report, hospitals and clinics accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America was the largest market for cardiac pacemaker. Some of the factors driving the North America cardiac pacemaker market included the growing incidences of cardiac disorders, rising geriatric population, the launch of MRI-compatible pacemakers and Bluetooth-enabled pacemakers, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global cardiac pacemaker market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, Biotronik, Boston Scientific Corporation, Lepu Medical Technology (Beijing)Co. Ltd., MEDICO s.r.l., Medtronic plc, MicroPort Scientific Corporation, Oscor Inc. (Integer Holdings Corporation), Osypka Medical GmbH., Shree Pacetronix Ltd., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. How big is the global cardiac pacemaker market?
  • 2. What is the expected growth rate of the global cardiac pacemaker market during 2024-2032?
  • 3. What are the key factors driving the global cardiac pacemaker market?
  • 4. What has been the impact of COVID-19 on the global cardiac pacemaker market?
  • 5. What is the breakup of the global cardiac pacemaker market based on the type?
  • 6. What is the breakup of the global cardiac pacemaker market based on the technology?
  • 7. What is the breakup of the global cardiac pacemaker market based on the indication?
  • 8. What is the breakup of the global cardiac pacemaker market based on the end user?
  • 9. What are the key regions in the global cardiac pacemaker market?
  • 10. Who are the key players/companies in the global cardiac pacemaker market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cardiac Pacemaker Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Implantable
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 External
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Biventricular
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Single Chambered
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Dual Chambered
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Indication

  • 8.1 Arrhythmias
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Congestive Heart Failure
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Ambulatory Surgery Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Biotronik
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 SWOT Analysis
    • 15.3.3 Boston Scientific Corporation
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Lepu Medical Technology (Beijing)Co. Ltd.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 MEDICO s.r.l.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Medtronic plc
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 MicroPort Scientific Corporatio
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Oscor Inc. (Integer Holdings Corporation)
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Osypka Medical GmbH
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Shree Pacetronix Ltd.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Cardiac Pacemaker Market: Major Drivers and Challenges
  • Figure 2: Global: Cardiac Pacemaker Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Cardiac Pacemaker Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Cardiac Pacemaker Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Cardiac Pacemaker Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Cardiac Pacemaker Market: Breakup by Indication (in %), 2023
  • Figure 7: Global: Cardiac Pacemaker Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Cardiac Pacemaker Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Cardiac Pacemaker (Implantable) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Cardiac Pacemaker (Implantable) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Cardiac Pacemaker (External) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Cardiac Pacemaker (External) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Cardiac Pacemaker (Biventricular) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Cardiac Pacemaker (Biventricular) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Cardiac Pacemaker (Single Chambered) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Cardiac Pacemaker (Single Chambered) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Cardiac Pacemaker (Dual Chambered) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Cardiac Pacemaker (Dual Chambered) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Cardiac Pacemaker (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Cardiac Pacemaker (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Cardiac Pacemaker (Arrhythmias) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Cardiac Pacemaker (Arrhythmias) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Cardiac Pacemaker (Congestive Heart Failure) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Cardiac Pacemaker (Congestive Heart Failure) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Cardiac Pacemaker (Other Indications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Cardiac Pacemaker (Other Indications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Cardiac Pacemaker (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Cardiac Pacemaker (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Cardiac Pacemaker (Ambulatory Surgery Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Cardiac Pacemaker (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Cardiac Pacemaker (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Cardiac Pacemaker (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: North America: Cardiac Pacemaker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: North America: Cardiac Pacemaker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: United States: Cardiac Pacemaker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: United States: Cardiac Pacemaker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Canada: Cardiac Pacemaker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Canada: Cardiac Pacemaker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Asia-Pacific: Cardiac Pacemaker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Asia-Pacific: Cardiac Pacemaker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: China: Cardiac Pacemaker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: China: Cardiac Pacemaker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Japan: Cardiac Pacemaker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Japan: Cardiac Pacemaker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: India: Cardiac Pacemaker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: India: Cardiac Pacemaker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: South Korea: Cardiac Pacemaker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: South Korea: Cardiac Pacemaker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Australia: Cardiac Pacemaker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Australia: Cardiac Pacemaker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Indonesia: Cardiac Pacemaker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Indonesia: Cardiac Pacemaker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Others: Cardiac Pacemaker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Others: Cardiac Pacemaker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Europe: Cardiac Pacemaker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Europe: Cardiac Pacemaker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Germany: Cardiac Pacemaker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Germany: Cardiac Pacemaker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: France: Cardiac Pacemaker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: France: Cardiac Pacemaker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: United Kingdom: Cardiac Pacemaker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: United Kingdom: Cardiac Pacemaker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Italy: Cardiac Pacemaker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Italy: Cardiac Pacemaker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Spain: Cardiac Pacemaker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Spain: Cardiac Pacemaker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Russia: Cardiac Pacemaker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Russia: Cardiac Pacemaker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Others: Cardiac Pacemaker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Others: Cardiac Pacemaker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Latin America: Cardiac Pacemaker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Latin America: Cardiac Pacemaker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Brazil: Cardiac Pacemaker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Brazil: Cardiac Pacemaker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Mexico: Cardiac Pacemaker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Mexico: Cardiac Pacemaker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Others: Cardiac Pacemaker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Others: Cardiac Pacemaker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Middle East and Africa: Cardiac Pacemaker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Middle East and Africa: Cardiac Pacemaker Market: Breakup by Country (in %), 2023
  • Figure 81: Middle East and Africa: Cardiac Pacemaker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Global: Cardiac Pacemaker Industry: Drivers, Restraints, and Opportunities
  • Figure 83: Global: Cardiac Pacemaker Industry: Value Chain Analysis
  • Figure 84: Global: Cardiac Pacemaker Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cardiac Pacemaker Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Cardiac Pacemaker Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Cardiac Pacemaker Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Cardiac Pacemaker Market Forecast: Breakup by Indication (in Million US$), 2024-2032
  • Table 5: Global: Cardiac Pacemaker Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Cardiac Pacemaker Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Cardiac Pacemaker Market: Competitive Structure
  • Table 8: Global: Cardiac Pacemaker Market: Key Players